BioMed Realty Trust, Inc. (BMR) Reports In-Line Q2 FFO, Revenues Top Slightly
Tweet
Share
E-mailGet Alerts BMR Hot Sheet
Price: $1.43 -4.03%
Financial Fact:
General and administrative: 13.17M
Today's EPS Names:
PKE, LNN, More
Financial Fact:
General and administrative: 13.17M
Today's EPS Names:
PKE, LNN, More
Join SI Premium – FREE
BioMed Realty Trust, Inc. (NYSE: BMR) reported Q2 FFO of $0.29, in-line with the analyst estimate of $0.29. Revenue for the quarter came in at $106.8 million versus the consensus estimate of $105.56 million.
BioMed Realty Trust, Inc. sees FY2011 FFO of $1.16-$1.20, versus the consensus of $1.18.
BioMed Realty Trust, Inc. sees FY2011 FFO of $1.16-$1.20, versus the consensus of $1.18.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla Q2 deliveries reach 480,126, topping estimates of 406,024
- Biogen expects $164M R&D charge to hit Q2 2026 earnings
- Constellation Brands (STZ) Tops Q1 EPS by 18c
Create E-mail Alert Related Categories
Earnings, GuidanceSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
